GlaxoSmithKline leads large European issuers in USD deals
Glaxosmithkline yesterday launched a $5 billion debt deal as non-US issuers look to the dollar markets for funding.
CLOs
- Middle market portfolios aren't immune to rate stress, according to new research 2 days ago
- Sona prices CLO number two 2 days ago
- Another 2016 vintage CLO gets reset as Octagon stays busy 2 days ago
- Neuberger Berman resets 2016 vintage for second time 2 days ago
- Beach Point brings in tight price for third US CLO 2 days ago